BCL2 and breast cancer: Pathway analysis also showed that miRNA-30a-3p was positively correlated with BCL2-mediated cellular survival/ceramide-induced apoptosis, which corresponded with a favorable role for increased BCL2 expression in breast cancer treated with endocrine therapy.